Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis;Zerebrale und spinale MRT-untersuchung bei patienten mit klinisch isoliertem syndrom oder gesicherter multipler sklerose

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 180, Issue 11, 2008, Pages 994-1001

  Sailer, Michael ^a,f   Fazekas, F ^a   Gass, A ^b   Kappos, L ^b   Radue, E W ^c   Rieckmann, P ^c   Toyka, K ^d   Wiendl, H ^d   Bendszus, M ^e  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Diagnosis; Disease monitoring; Magnet resonance imaging; Multiple sclerosis

Indexed keywords

ARTICLE; CORPUS CALLOSUM; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; BRAIN; DIFFERENTIAL DIAGNOSIS; METHODOLOGY; PATHOLOGY; REVIEW; SPINE;

CONTRAST MEDIUM;

BRAIN; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; SPINE;

EID: 56149100106     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027817     Document Type: Article

References (38)

1. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127
2. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: Revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846
3. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231
4. Barkhof F, Filippi M, Miller DH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069
5. Dalton CM, Brex PA, Miszkiel KA et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002; 52: 47-53
6. Korteweg T, Tintore M, Uitdehaag B et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006; 5: 221-227
7. Tintore M, Rovira A, Rio J et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003; 60: 27-30
8. Brex PA, Ciccarelli O, O'Riordan JI et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158-164
9. Sailer M, O'Riordan JI, Thompson AJ et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology, 1998; 52: 599-606
10. Kappos L, Freedman MS, Polman C et al. Effect of early versus delayed interferon beta 1-b treatment on disability after first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007; 370: 363-364
11. Multiple Sclerosis Consensus Group Basic and escalating immunomodulatory treatments in multiple sclerosis. J Neurol 2008: (in press)
12. Tintore M, Rovira A, Martinez MJ et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 702-706
13. Filippi M, Marciano N, Capra R et al. The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis. Neurology 1997; 49: 274-276
14. Gallagher HL, MacManus DG, Webb SL et al. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis. J Magn Reson Imaging 1997; 7: 439-441
15. Filippi M, Rocca MA, Arnold DL et al. EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis. Eur J Neurol 2006; 13: 313-325
16. Gass A, Radu EW, Filippi M et al. MRT-Verlaufsuntersuchungen bei multipler Sklerose. Ein Leitfaden für die Qualitätssicherung. Röntgenstr Fortschr 1999; 170: 581-586
17. Simon JH, Li D, Traboulsee A et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol 2006; 27: 455-461
18. Miller DH, Filippi M, Fazekas F et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 2004; 56: 273-278
19. Palmer S, Bradley WG, Chen DY et al. Subcallosal striations: early Findings of multiple sclerosis on sagittal, thin-section, fast FLAIR MR images. Radiology 1999; 210: 149-153
20. Fazekas F, Barkhof F, Filippi M et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999; 53: 448-456
21. Filippi M, Horsfield MA, Campi A et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995; 38: 749-754
22. Kappos L, Moeri D, Radue EW et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 1999; 353: 964-969
23. Tas MW, Barkhol F, van Walderveen MA et al. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 1995; 16: 259-264
24. Fazekas F, Soelberg-Sorensen P, Comi G et al. MRI to monitor treatment efficacy in multiple sclerosis. J Neuroimaging Suppl 2007; 1: 50-55
25. Filippi M, van Waesberghe JH, Horsfield MA et al. Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. Neurology 1997; 49: 371-377
26. Schima W, Wimberger D, Schneider B et al. Bedeutung der Magnetfeldstärke in der MR-Diagnostik der multiplen Sklerose: Ein Vergleich von 0,5 und 1,5 T. Röntgenstr Fortschr 1993; 158: 368-371
27. Wang Y. Description of parallel imaging in MRI using multiple coils. Magn Reson Med 2007; 44: 495-499
28. Wattjes MP, Harzheimer M, Kuhl CK et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current mr imaging criteria for multiple sclerosis? AJNR Am J Neuroradiol 2006; 27: 1794-1798
29. Rossi C, Boss A, Lindig TM et al. Diffusion tensor imaging of the spinal cord at 1.5 and 3.0 Tesla. Röntgenstr Fortschr 2007; 179: 219-224
30. Bot JC, Blezer EL, Kamphorst W et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 2005; 233: 531-540
31. Bot JC, Barkhof F, Nijeholt GJ et al. Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis. Eur Radiol 2000; 10: 753-758
32. Rocca MA, Mastronardo G, Horsfield MA et al. Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol 1999; 20: 1710-1716
33. Bot JC, Barkhof F, Nijeholt G et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002; 223: 46-56
34. Dalton CM, Brex PA, Miszkiel KA et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 2003; 53: 673-676
35. Gass A, Filippi M, Rodegher ME et al. Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI. Neurology 1998; 50: 548-550
36. Linn J, Hoffmann LA, Danek A et al. Differenzialdiagnose bilateraler Thalamusläsionen. Röntgenstr Fortschr 2007; 179: 234-245
37. Lycklama G, Thompson A, Filippi M et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2003; 2: 555-562
38. Nielsen JM, Korteweg T, Barkhof F et al. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol 2005; 58: 781-783